CUAMC
CGEM icon

China Universal Asset Management Company’s Cullinan Oncology CGEM Stock Holding History

China Universal Asset Management Company’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$149K Buy
10,484
+858
+9% +$11K 0.01% 376
2025
Q4 		$99.6K Sell
9,626
-729
-7% -$6.58K 0.01% 412
2025
Q3 		$61.4K Sell
10,355
-1,498
-13% -$11K 0.01% 418
2025
Q2 		$89.3K Buy
11,853
+116
+1% +$932 0.01% 375
2025
Q1 		$88.8K Sell
11,737
-609
-5% -$5.84K 0.01% 365
2024
Q4 		$150K Buy
12,346
+1,195
+11% +$17.2K 0.01% 350
2024
Q3 		$187K Buy
11,151
+4,380
+65% +$77.7K 0.02% 309
2024
Q2 		$118K Sell
6,771
-2,225
-25% -$47.4K 0.02% 292
2024
Q1 		$153K Buy
8,996
+4,042
+82% +$62.5K 0.02% 324
2023
Q4 		$50.5K Buy
4,954
+3,859
+352% +$34.2K 0.01% 370
2023
Q3 		$9.91K Buy
1,095
+579
+112% +$6.03K ﹤0.01% 346
2023
Q2 		$5.55K Sell
516
-17
-3% -$181 ﹤0.01% 360
2023
Q1 		$5.45K Buy
533
+68
+15% +$750 ﹤0.01% 358
2022
Q4 		$4.91K Buy
465
+38
+9% +$462 ﹤0.01% 299
2022
Q3 		$5K Buy
+427
New +$5.75K ﹤0.01% 268

Other funds holding CGEM

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

China Universal Asset Management Company's CGEM Position: Q1 2026 in Review

China Universal Asset Management Company increased its Cullinan Oncology (CGEM) stake by 8.9% in Q1 2026, buying an estimated $11K and bringing the position to 10,484 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #376.

China Universal Asset Management Company first reported a position in CGEM in Q3 2022 and has held it in 15 quarters since. The position peaked at $187K in Q3 2024. 174 funds tracked by Wall St. Rank hold CGEM as of Q1 2026.

  • China Universal Asset Management Company held 10,484 shares of Cullinan Oncology worth $149K as of Q1 2026.
  • China Universal Asset Management Company bought 858 Cullinan Oncology shares in Q1 2026, an estimated $11K.
  • Cullinan Oncology made up 0.01% of China Universal Asset Management Company's portfolio in Q1 2026, its #376 holding.
  • China Universal Asset Management Company first reported a position in Cullinan Oncology in Q3 2022 and has held it in 15 quarters since.
  • China Universal Asset Management Company's Cullinan Oncology position peaked at $187K in Q3 2024.
  • 174 funds tracked by Wall St. Rank held Cullinan Oncology as of Q1 2026.

Based on China Universal Asset Management Company's 13F filing for Q1 2026, filed 28 Apr 2026.